(19)
(11)
EP 0 397 798 A1
(12)
(43)
Date of publication:
22.11.1990
Bulletin 1990/47
(21)
Application number:
89902872.0
(22)
Date of filing:
03.02.1989
(51)
International Patent Classification (IPC):
C12P
21/
08
( . )
A61K
45/
00
( . )
A61P
29/
00
( . )
C07K
14/
00
( . )
C07K
14/
42
( . )
C07K
14/
715
( . )
C07K
19/
00
( . )
A61K
39/
395
( . )
A61K
47/
48
( . )
A61P
37/
06
( . )
C07K
14/
415
( . )
C07K
14/
705
( . )
C07K
16/
00
( . )
C12R
1/
91
( . )
(86)
International application number:
PCT/US1989/000440
(87)
International publication number:
WO 1989/006968
(
10.08.1989
Gazette 1989/18)
(84)
Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE
(30)
Priority:
03.02.1988
US 19880151744
(71)
Applicant:
Xoma Corporation
Berkeley California 94710 (US)
(72)
Inventors:
SCANNON, Patrick, J.
Davis, CA 95616 (US)
HARMON, Richard, C.
Walnut Creek, CA 94595 (US)
(74)
Representative:
Glawe, Delfs, Moll & Partner
Patentanwälte Postfach 26 01 62
D-80058 München
D-80058 München (DE)
(54)
THERAPEUTIC USE OF ANTI-T CELL IMMUNOTOXIN FOR AUTOIMMUNE DISEASES